All Practice Exams

Free Practice Questions for Medical Laboratory Scientist

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card
100+ Questions
100% Free

Loading practice questions...

Exam Review

Key Facts: Medical Laboratory Scientist Exam

3 levels

Laboratory Worker, Academic, Senior

Ministry of Health — medical laboratory licensing page

2 / year

Sittings (15.02.2026, 07.09.2026)

Ministry of Health — medical laboratory licensing page

01.01.2026

Updated Syllabi in Force

Ministry of Health — medical laboratory licensing page

60 / 90 days

Registration Deadline (Standard / Senior)

Ministry of Health — medical laboratory licensing page

6

Languages the Exam May Be Sat In

Ministry of Health — medical laboratory licensing page

100

Practice Questions

OpenExamPrep Practice Bank

Israel's government examinations in medical laboratory science are multiple-choice papers sat twice a year at Binyanei Ha'uma in Jerusalem and, from this year, taken on laptops, with separate examinations and syllabi for laboratory worker / academic laboratory worker status and for senior laboratory worker status. This 100-question set is independent English-language practice by OpenExamPrep across clinical biochemistry, haematology and coagulation, microbiology, transfusion medicine and immunology and laboratory quality management.

Sample Medical Laboratory Scientist Practice Questions

Try these sample questions to review concepts for the Medical Laboratory Scientist exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1In clinical enzymology, how does a reversible competitive enzyme inhibitor affect the kinetic parameters Vmax and Km on a Lineweaver-Burk double-reciprocal plot?
A.Vmax decreases while Km remains unchanged, shifting the y-intercept upward.
B.Km increases while Vmax remains unchanged, shifting the x-intercept closer to zero.
C.Both Vmax and Km decrease proportionally, producing parallel lines.
D.Vmax increases while Km decreases, shifting both intercepts away from zero.
Explanation: A competitive inhibitor competes directly with substrate for the active binding site, requiring a higher substrate concentration to achieve half-maximal velocity, which increases the apparent Km (shifting the x-intercept, -1/Km, closer to zero). Because the inhibition can be completely overcome by saturating concentrations of substrate, the maximum velocity (Vmax) remains unaltered, leaving the y-intercept (1/Vmax) unchanged.
2When measuring diagnostic enzyme activities (e.g., AST, ALT, CK) in automated clinical chemistry analyzers, which reaction condition must be maintained to ensure zero-order kinetics?
A.Substrate concentration must be significantly lower than Km ([S] << Km) so the rate depends only on substrate availability.
B.Cofactor concentrations must be depleted continuously to prevent reverse product formation.
C.Substrate concentration must be maintained in large excess ([S] >> Km, typically 10 to 100 times Km) so the reaction rate is directly proportional to active enzyme concentration.
D.The reaction temperature must fluctuate between 25°C and 45°C to prevent enzyme denaturation during extended incubation.
Explanation: To quantitate active enzyme concentration accurately, the enzymatic reaction must operate under zero-order kinetics, where the reaction velocity is independent of substrate concentration and directly proportional to enzyme concentration. This is achieved by ensuring that substrate is present in vast molar excess ([S] >> Km, typically 10-100 × Km), ensuring that all enzyme catalytic sites remain fully saturated throughout the measurement window.
3A serum sample from a patient presenting with crushing chest pain displays an inverted lactate dehydrogenase (LDH) isoenzyme pattern, where LD-1 activity exceeds LD-2 (the 'flipped' LD pattern). What clinical condition does this electropherogram classically indicate?
A.Acute myocardial infarction or in vivo hemolytic anemia.
B.Acute viral hepatitis with centrilobular hepatocellular necrosis.
C.Acute pancreatitis with retroperitoneal inflammation.
D.Severe pulmonary embolism with pulmonary infarction.
Explanation: In healthy individuals, serum LD-2 is higher than LD-1. Because myocardial tissue and mature erythrocytes contain abundant LD-1 (tetramer composed of four H subunits, H4), acute myocardial infarction or intravascular hemolysis causes a massive release of LD-1 into the circulation, creating a 'flipped' LD pattern where LD-1 > LD-2.
4An adult patient presents with an isolated elevation of total alkaline phosphatase (ALP) with normal transaminases and bilirubin. To distinguish whether the ALP elevation originates from bone or liver tissue using heat inactivation, what is the expected residual activity after incubation at 56°C for 10 minutes?
A.Both liver and bone isoenzymes are 100% inactivated at 56°C.
B.Bone ALP retains more than 50% activity, whereas liver ALP retains less than 10% activity.
C.Placental ALP is completely destroyed at 56°C while bone ALP is fully stable.
D.Bone ALP is heat-labile and retains less than 20% residual activity, whereas liver ALP is relatively heat-stable and retains 30% to 50% activity.
Explanation: The mnemonic 'bone burns, liver lives' reflects the heat inactivation properties of alkaline phosphatase isoenzymes at 56°C for 10 minutes. Bone ALP is notably heat-labile, typically retaining less than 20% of its initial catalytic activity, whereas liver ALP is more heat-stable, retaining between 30% and 50% residual activity (placental ALP is exceptionally heat-stable, surviving even 65°C incubation).
5A 45-year-old patient presents to the emergency department with acute epigastric pain radiating to the back 48 hours after symptom onset. Why is serum lipase measurement considered clinically superior to serum amylase in confirming acute pancreatitis?
A.Amylase is entirely cleared from circulation within 6 hours of pancreatic injury.
B.Lipase remains elevated significantly longer (up to 8-14 days) and has greater clinical sensitivity and pancreatic tissue specificity than amylase.
C.Lipase is filtered and reabsorbed by the proximal tubules, preventing urinary loss and making serum testing obsolete.
D.Amylase only rises in chronic calcific pancreatitis and remains normal during acute necrotizing attacks.
Explanation: Serum lipase rises within 4 to 8 hours of acute pancreatitis, peaks at 24 hours, and remains elevated for 8 to 14 days, whereas serum amylase normalizes within 48 to 72 hours due to rapid renal clearance. Furthermore, amylase is produced by salivary glands, ovaries, and lungs, making lipase both more sensitive for delayed presentations and substantially more specific for acute acinar cell destruction.
6A comatose patient admitted with suspected toxic ingestion exhibits the following laboratory findings: Na+ 140 mmol/L, K+ 4.5 mmol/L, Cl- 98 mmol/L, HCO3- 12 mmol/L. What is the calculated serum anion gap (without potassium) and what type of acid-base disturbance does it indicate?
A.30 mmol/L; High anion gap metabolic acidosis (HAGMA).
B.16 mmol/L; Normal anion gap (hyperchloremic) metabolic acidosis.
C.42 mmol/L; Combined respiratory and metabolic alkalosis.
D.24 mmol/L; Laboratory analytical error due to unmeasured cations.
Explanation: The serum anion gap calculated without potassium is [Na+] - ([Cl-] + [HCO3-]). Substituting the patient values gives 140 - (98 + 12) = 140 - 110 = 30 mmol/L. Normal reference range is 8-16 mmol/L (or 8-12 mmol/L depending on analyzer methodology). An anion gap of 30 mmol/L confirms a severe high anion gap metabolic acidosis (HAGMA), commonly caused by diabetic ketoacidosis, lactic acidosis, uremia, or ingestions (methanol, ethylene glycol, salicylate).
7A patient with severe multiple myeloma and a total serum protein of 13.5 g/dL has a serum sodium reported as 121 mmol/L on an automated analyzer using indirect ion-selective electrode (ISE) potentiometry. A direct ISE measurement on a blood gas analyzer reports a sodium of 139 mmol/L. What analytical phenomenon accounts for this discrepancy?
A.Protein binding of sodium ions inside the arterial heparin syringe.
B.Denaturation of the ion-selective crown ether membrane by monoclonal paraproteins.
C.Electrolyte exclusion effect (pseudohyponatremia) caused by sample pre-dilution in indirect ISE.
D.Rapid in vitro consumption of free sodium by proliferating plasma cells.
Explanation: Indirect ISE requires a pre-dilution step (typically 1:20 or 1:30) of the whole serum aliquot, assuming that 93% of serum volume is water and 7% is solid phase (proteins and lipids). When paraproteins or triglycerides are severely elevated, the non-aqueous solid fraction expands significantly, reducing the actual water content in the measured pipetted aliquot; when the instrument calculates the concentration back to total volume, it falsely underestimates the physiological electrolyte concentration (pseudohyponatremia). Direct ISE does not dilute the sample and measures the true electrolyte activity in the plasma water phase.
8An arterial blood gas (ABG) sample drawn from an intensive care patient with chronic obstructive pulmonary disease (COPD) yields: pH 7.34, pCO2 62 mmHg, HCO3- 32 mmol/L, pO2 65 mmHg. How should the clinical laboratory evaluate this acid-base profile?
A.Fully compensated acute metabolic acidosis with respiratory hyperventilation.
B.Partially compensated respiratory acidosis with renal bicarbonate retention.
C.Uncompensated acute respiratory alkalosis secondary to hypoxemic drive.
D.Primary metabolic alkalosis with complete hypoventilatory compensation.
Explanation: The pH of 7.34 is acidic (< 7.35). The primary etiology is alveolar hypoventilation causing carbon dioxide retention (pCO2 62 mmHg > 45 mmHg). In response to sustained respiratory acidosis, the kidneys retain bicarbonate over 48 to 72 hours, resulting in a compensatory elevation of plasma bicarbonate to 32 mmol/L (> 26 mmol/L). Because the pH remains slightly below the normal range (7.35-7.45), the disorder is categorized as partially compensated respiratory acidosis.
9A laboratory technologist notes a visible air bubble occupying approximately 10% of an arterial blood gas syringe that was delivered on ice 20 minutes after sampling. How will exposure to room air affect the measured pO2 and pCO2 values?
A.pO2 decreases significantly while pCO2 increases proportionally.
B.Both pO2 and pCO2 increase due to ambient gas dissolution.
C.Both pO2 and pCO2 decrease due to rapid atmospheric equilibration.
D.pO2 increases (equilibrating toward room air pO2 ~150 mmHg) while pCO2 decreases (equilibrating toward room air pCO2 ~0.3 mmHg).
Explanation: Atmospheric air contains approximately 21% O2 (pO2 ~150 mmHg) and <0.04% CO2 (pCO2 ~0.3 mmHg). When an arterial blood gas sample with a typical physiological pO2 (~80-100 mmHg) and pCO2 (~40 mmHg) is exposed to an air bubble, oxygen diffuses from the bubble into the blood (falsely increasing measured pO2), while carbon dioxide diffuses out of the blood into the bubble (falsely decreasing measured pCO2 and consequently elevating pH).
10A routine serum biochemistry sample arrives from an outpatient clinic. The analyzer reports a potassium of 6.8 mmol/L and an optical hemolysis index (H-index) corresponding to 350 mg/dL free hemoglobin. What is the correct laboratory action and underlying mechanism?
A.Cancel the potassium result, add an interpretive comment regarding pseudohyperkalemia due to in vitro erythrocyte lysis, and request a fresh unhemolyzed redraw.
B.Report the potassium value without comment because intra-erythrocyte and extracellular potassium concentrations are identical.
C.Multiply the measured potassium by 0.5 to mathematically adjust for the release of red cell potassium.
D.Centrifuge the tube a second time at 4,000 g for 15 minutes to precipitate free hemoglobin before re-analyzing.
Explanation: Mature erythrocytes contain approximately 105 mmol/L of potassium compared to 3.5-5.0 mmol/L in normal extracellular serum (an intracellular-to-extracellular ratio of ~25:1). In vitro hemolysis ruptures erythrocytes, releasing massive quantities of intracellular potassium into the serum, producing severe pseudohyperkalemia. The laboratory must suppress/cancel the spurious result, document hemolysis interference, and request a properly drawn replacement specimen.

About the Medical Laboratory Scientist Exam

The Israeli Medical Laboratory Sciences Licensing Examination (בחינת רישוי לעובדי מעבדה רפואית אקדמאים) is the statutory qualifying examination established under the Public Health Regulations (Medical Laboratories), 5737-1977 (תקנות בריאות העם (מעבדות רפואיות), התשל"ז-1977). Passing this examination is required to obtain official recognition of status (תעודת הכרה במעמד) as an academic medical laboratory worker (עובד מעבדה רפואית אקדמאי) from the Ministry of Health, granting independent clinical testing authority in hospital, HMO (קופות חולים), and reference diagnostic laboratories across Israel. The Ministry lets candidates sit the examination in Hebrew, Arabic, English, Russian, French or Spanish, but anyone sitting it in a language other than Hebrew must first prove Hebrew proficiency at ulpan level ג'; this practice bank is an independent English-language study adaptation authored by OpenExamPrep and is not an official translation or government examination pool.

Exam sponsor: Ministry of Health (משרד הבריאות) — Medical Professions Licensure Division with the Laboratories Department. The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

Multiple-choice ('American-style') government examination, now sat on laptops instead of printed question and answer sheets, at the International Convention Center (Binyanei Ha'uma), Jerusalem. Separate examinations are held for medical laboratory worker and academic medical laboratory worker status and for senior medical laboratory worker status, each against its own published syllabus. The paper is translated into English, Arabic, Russian, French or Spanish when that language is marked on the registration form.

Time Limit

Not published by the Ministry of Health

Passing Score

Pass/fail determined by the examination committee; no numeric pass mark is published

Exam / Certification Fees

Statutory examination fee set in the Ministry of Health fee schedule; it must be paid through the government payments service before the examination

Exam sponsor website

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

25%

Clinical Biochemistry

Enzyme kinetics, ion-selective electrodes, blood gas acid-base calculations (Henderson-Hasselbalch), renal function (creatinine clearance, eGFR), hepatic panels, cardiac troponin I/T, endocrine immunoassays, and analytical interferences (HIL indices).

25%

Hematology & Coagulation

Complete blood count impedance and optical scatter principles, microcytic vs macrocytic anemias, hemoglobinopathies, bone marrow morphology, acute leukemias (FAB/WHO), flow cytometry CD markers, PT/INR, aPTT, mixing studies, and thrombophilias.

20%

Medical Microbiology & Parasitology

Gram-stain and acid-fast stains, selective and differential culture media, automated identification (MALDI-TOF), CLSI/EUCAST disk diffusion and broth microdilution MIC interpretation, diagnostic PCR, stool parasitology, and opportunistic fungi.

15%

Transfusion Medicine & Immunohematology

ABO and Rh system genetics, forward/reverse typing discrepancies, antibody screening and 11-cell identification panels, direct and indirect antiglobulin tests, crossmatch compatibility, and acute/delayed hemolytic transfusion reaction workups.

15%

Immunology, Serology & Laboratory Quality/Safety

Automated immunoassays (ELISA, ECLIA), autoimmune serology (ANA patterns, ANCA, anti-dsDNA), Levey-Jennings quality control charts, Westgard multi-rules, biosafety containment levels, chemical hazard handling, and Israeli Public Health Regulations 5737-1977.

Preparing for the Medical Laboratory Scientist Exam

What You Need to Know

  • Passing score: Pass/fail determined by the examination committee; no numeric pass mark is published
  • Assessment: Multiple-choice ('American-style') government examination, now sat on laptops instead of printed question and answer sheets, at the International Convention Center (Binyanei Ha'uma), Jerusalem. Separate examinations are held for medical laboratory worker and academic medical laboratory worker status and for senior medical laboratory worker status, each against its own published syllabus. The paper is translated into English, Arabic, Russian, French or Spanish when that language is marked on the registration form.
  • Time limit: Not published by the Ministry of Health
  • Exam / certification fees: Statutory examination fee set in the Ministry of Health fee schedule; it must be paid through the government payments service before the examination Official sources

Using Our Practice Resources

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Medical Laboratory Scientist: Suggested Study Strategy

1Master Westgard multi-rule evaluation: understand which violations indicate random analytical error (such as 1-3s and R-4s) versus systematic error (such as 2-2s, 4-1s, and 10-x).
2Memorize coagulation pathway cascades and mixing study protocols: know how to distinguish factor deficiencies from lupus anticoagulant inhibitors using normal pooled plasma incubation.
3Review blood bank antibody panel resolution: utilize the rule of three, antigen cross-out techniques, and enzyme treatment effects (e.g., Fya/Fyb destroyed by ficin, Rh antigens enhanced).
4Understand spectrophotometric interference mechanisms: learn how hemolysis, icterus, and lipemia (HIL indices) affect enzymatic and colorimetric assays.
5Know the statutory requirements of the Public Health Regulations 5737-1977, including critical value notification mandates, specimen retention periods, and laboratory director qualifications.

Frequently Asked Questions

What is the passing score and format of the Israeli Medical Laboratory Licensing Exam?

The Ministry of Health publishes the format - a multiple-choice ('American-style') paper, now taken on laptops rather than printed question and answer sheets - together with the sitting dates, the translation options and the appeal rules, For the academic medical laboratory worker paper the Ministry states that it contains 100 multiple-choice questions drawn from the published syllabus, but it does not publish the duration or a numeric pass mark. Any candidate who fails may register for the review day within 7 days of the results message, inspect the paper for an hour and appeal within 10 days of that inspection. Separate examinations and syllabi apply to laboratory worker / academic laboratory worker status and to senior laboratory worker status.

Is this practice bank an official exam simulator or official translation?

No. The official Israeli licensing examination is written in Hebrew and offered by the Ministry of Health in Hebrew, Arabic, English, Russian, French or Spanish, with proof of Hebrew proficiency required from candidates who sit it in another language. This question bank is an independent English-language educational adaptation authored by OpenExamPrep to assist academic graduates in reviewing laboratory science theory, diagnostic interpretation, and Israeli regulatory guidelines. It is not an official government exam pool.

Who is eligible to take the examination in Israel?

Holders of a bachelor's degree in medical laboratory sciences, or of a degree in medical sciences, life sciences, chemistry, agriculture, biotechnology, veterinary medicine, pharmacy or nutrition (or an MD), who complete a supervised internship (סטאז') in a Ministry-recognised medical laboratory - six consecutive months full time for a bachelor's degree, four months for a master's and three months for a PhD. Graduates whose medical laboratory sciences degree already included the internship are exempt from both the internship and the examination.

What legal authority governs medical laboratory workers in Israel?

Medical laboratories and their professional personnel operate under the Public Health Regulations (Medical Laboratories), 5737-1977 (תקנות בריאות העם (מעבדות רפואיות), התשל"ז-1977), supervised by the Division of Medical Laboratories within the Israeli Ministry of Health.

What happens if a candidate fails the licensing examination?

A candidate who fails may register and pay the statutory examination fee set by the Ministry of Health again for a later sitting; there is no published cap on attempts. Any candidate who fails may register for the review day within 7 days of the results message, inspect the paper for one hour and submit a written appeal within 10 days of the inspection; the Ministry publishes the appeal committee's decisions after each sitting.